Portfolio Companies 2026 for Enavate Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Enavate Sciences accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.1B. The median disclosed raise is $179M, and the largest is BridgeBio Oncology Therapeutics at $200M, ahead of Braveheart Bio ($190M) and Sudo Biosciences ($188M).
The names that recur most often on these portfolio cap tables are Enavate Sciences (8 companies), Frazier Life Sciences (2 companies), Patient Square Capital (2 companies), Cormorant Asset Management (1 company), Omega Funds (1 company), Deerfield Management (1 company). By latest disclosed round, the market skews Series A (4), Series B (2), Growth (1), Series C (1).